elements
-live
Search elements, keywords, and sectors
🔎
Elements
Subjects
Papers
Pricing
Log in
Sign up
Home
/
Subjects
/
Chemoimmunotherapy
← Back to subjects
Current data, viewed at
Yearly
resolution.
Personal members see monthly resolution →
Keyword
keyword
Chemoimmunotherapy
RIS
0.001
(Research Intensity Score)
Papers
215
Top papers
Neoadjuvant chemo-immunotherapy with camrelizumab plus nab-paclitaxel and cisplatin in resectable locally advanced squamous cell carcinoma of the head and neck: a pilot phase II trial
2024 · 105 citations
Long-term outcomes for ibrutinib–rituximab and chemoimmunotherapy in CLL: updated results of the E1912 trial
2022 · 239 citations
Cyclometalated iridium(III) complex based on isoquinoline alkaloid synergistically elicits the ICD response and IDO inhibition via autophagy-dependent ferroptosis
2025 · 53 citations
Ibrutinib–Rituximab or Chemoimmunotherapy for Chronic Lymphocytic Leukemia
2019 · 743 citations
Potentiated Calcium Carbonate with Enhanced Calcium Overload Induction and Acid Neutralization Capabilities to Boost Chemoimmunotherapy against Liver Cancer
2024 · 41 citations
Engineering cell membrane-camouflaged COF-based nanosatellite for enhanced tumor-targeted photothermal chemoimmunotherapy
2024 · 37 citations
Ferroptosis-induced SUMO2 lactylation counteracts ferroptosis by enhancing ACSL4 degradation in lung adenocarcinoma
2025 · 21 citations
A phase 2 trial of risk enabled therapy after neoadjuvant chemo-immunotherapy for muscle-invasive bladder cancer (RETAIN-2).
2025 · 27 citations
Recent advances in antitumor Pt(IV) complexes: Dual targeting and chemoimmunotherapy
2025 · 22 citations
Newest papers
Oxoisoaporphine Alkaloid Piano-Stool Arene Ruthenium(II) Derivative: A cGAS-STING-Mediated Chemoimmunotherapy Inducer that Acts as a Dual Catalytic Inhibitor of Topoisomerase I/II
2026 · 3 citations
Lactate dehydrogenase-to-lymphocyte ratio predicts overall and progression-free survival among patients with advanced small-cell lung cancer receiving first-line chemoimmunotherapy
2026
Highlights from the 2025 ASH meeting: what’s new in lymphoma?
2026
Beyond the Scalpel: Why FLOT Changed Gastric Cancer—Biological Rationale, Evidence, and Regional Relevance
2026
Granulocyte colony-stimulating factor use does not impair efficacy of chemoimmunotherapy in advanced non-small cell lung cancer: a real-world retrospective study
2026
Safety and oncological efficacy of minimally invasive McKeown esophagectomy: A 10-year single-center experience of 808 consecutive patients operated by a single surgeon
2026
Exploring PDLIM2 as a prognostic biomarker and therapeutic target in lung adenocarcinoma
2026
ASO Visual Abstract: Neoadjuvant Chemoimmunotherapy Versus Standard Chemoradiotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma
2026
Small Cell Lung Cancer in Transition: Recent Advances in Biology, Treatment, and Precision Medicine
2026
Browse all papers →
Chemoimmunotherapy's history
Research intensity over time
Yearly
Personal members see monthly resolution →
Data temporarily unavailable — please try again shortly.
Close ✕
Chemoimmunotherapy's papers
Ordered by current research-activity contribution.
Loading…
Close ✕
Read full text ↗
Share
Share on X
Share on Facebook
Share on LinkedIn
Copy link